AU1734700A - Methods of treating tardive dyskinesia and other movement disorders - Google Patents
Methods of treating tardive dyskinesia and other movement disordersInfo
- Publication number
- AU1734700A AU1734700A AU17347/00A AU1734700A AU1734700A AU 1734700 A AU1734700 A AU 1734700A AU 17347/00 A AU17347/00 A AU 17347/00A AU 1734700 A AU1734700 A AU 1734700A AU 1734700 A AU1734700 A AU 1734700A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- movement disorders
- tardive dyskinesia
- treating tardive
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09193892 | 1998-11-18 | ||
US09/193,892 US6294583B1 (en) | 1998-01-13 | 1998-11-18 | Methods of treating tardive dyskinesia and other movement disorders |
PCT/US1999/027343 WO2000028999A2 (en) | 1998-11-18 | 1999-11-18 | Methods of treating tardive dyskinesia and other movement disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1734700A true AU1734700A (en) | 2000-06-05 |
Family
ID=22715448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17347/00A Abandoned AU1734700A (en) | 1998-11-18 | 1999-11-18 | Methods of treating tardive dyskinesia and other movement disorders |
Country Status (3)
Country | Link |
---|---|
US (3) | US6294583B1 (en) |
AU (1) | AU1734700A (en) |
WO (1) | WO2000028999A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040208875A1 (en) * | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
US6391922B1 (en) * | 1998-01-13 | 2002-05-21 | Synchroneuron, Llc | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
NZ543319A (en) * | 1999-04-28 | 2007-06-29 | Neurochem Int Ltd | Compositions and methods for treating amyloidosis using sulphonate derivatives |
US20020165246A1 (en) * | 2001-03-05 | 2002-11-07 | Andrew Holman | Administration of sleep restorative agents |
EP1436258A4 (en) * | 2001-03-08 | 2005-03-23 | Univ Emory | Ph-dependent nmda receptor antagonists |
US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
US20040037895A1 (en) * | 2002-08-23 | 2004-02-26 | Alex Zhu | Methods of treating involuntary facial spasms and facial wrinkles |
US7160913B2 (en) * | 2002-09-13 | 2007-01-09 | Thomas Jefferson University | Methods and kit for treating Parkinson's disease |
US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
US7414076B2 (en) * | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
WO2005037215A2 (en) * | 2003-10-14 | 2005-04-28 | Massachusetts Institute Of Technology | Compositions and methods for enhancing cognitive function and synaptic plasticity |
AU2005310986A1 (en) * | 2004-11-12 | 2006-06-08 | Bellus Health (International) Limited | Methods and fluorinated compositions for treating amyloid-related diseases |
AU2005310979A1 (en) * | 2004-11-16 | 2006-06-08 | Bellus Health (International) Limited | Compounds for the treatment of CNS and amyloid associated diseases |
AU2005326962A1 (en) | 2004-12-22 | 2006-08-17 | Bellus Health (International) Limited | Methods and compositions for treating amyloid-related diseases |
ES2819303T3 (en) * | 2005-04-05 | 2021-04-15 | Univ Yale | Glutamate modulating agents in the treatment of mental disorders |
TW200716088A (en) * | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
US20060252830A1 (en) * | 2005-05-06 | 2006-11-09 | Brandon Stephen F | Method for the treatment of magnesium and potassium deficiencies |
US20060252831A1 (en) * | 2005-05-06 | 2006-11-09 | Christopher Offen | Method for the treatment of magnesium and potassium deficiencies |
US8510055B2 (en) * | 2005-08-03 | 2013-08-13 | The Johns Hopkins University | Methods for characterizing and treating cognitive impairment in aging and disease |
WO2007125385A2 (en) * | 2005-12-22 | 2007-11-08 | Neurochem (International) Limited | Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
SG10201502642TA (en) | 2006-10-12 | 2015-05-28 | Bhi Ltd Partnership | Methods, Compounds, Compositions And Vehicles For Delivering 3-Amino-1-Propanesulfonic Acid |
GB0623897D0 (en) * | 2006-11-30 | 2007-01-10 | Pliva Istrazivanje I Razvoj D | Pharmaceutical composition of memantine |
JP2010529947A (en) * | 2006-12-22 | 2010-09-02 | ベラス ヘルス(インターナショナル)リミテッド | Methods, compounds, and compositions for treating metabolic diseases and diabetes |
US8163301B2 (en) * | 2007-03-22 | 2012-04-24 | Magceutics, Inc. | Magnesium compositions and uses thereof for metabolic disorders |
JP2010532382A (en) * | 2007-06-29 | 2010-10-07 | エモリー・ユニバーシテイ | NMDA receptor antagonist for neuroprotection |
US20090082464A1 (en) * | 2007-09-07 | 2009-03-26 | Bernd Jandeleit | Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
TW200924746A (en) * | 2007-09-07 | 2009-06-16 | Xenoport Inc | Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
WO2009052191A1 (en) * | 2007-10-15 | 2009-04-23 | Xenoport, Inc. | Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
JP5688035B2 (en) | 2009-02-12 | 2015-03-25 | インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション | Substances and methods for treating developmental disorders including comorbid and idiopathic autism |
US8377473B2 (en) * | 2009-07-01 | 2013-02-19 | Magceutics, Inc. | Slow release magnesium composition and uses thereof |
EP2621487B1 (en) | 2010-09-28 | 2017-05-03 | Depomed, Inc. | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract |
EP2640391B1 (en) | 2010-11-15 | 2015-11-11 | Agenebio, Inc. | Pyridazine derivatives, compositions and methods for treating cognitive impairment |
US20130143867A1 (en) | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
CA2914365C (en) | 2013-06-05 | 2022-03-15 | Synchroneuron, Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
CA3123897C (en) | 2013-12-20 | 2024-02-06 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
WO2016205739A1 (en) | 2015-06-19 | 2016-12-22 | Belew Mekonnen | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
CN105389460B (en) * | 2015-10-19 | 2018-09-11 | 苏华巍 | Tcm constitution screens expert system and its control method |
BR112019012821A2 (en) | 2016-12-19 | 2019-11-26 | Agenebio Inc | benzodiazepine derivatives, compositions and methods for the treatment of cognitive impairment |
CN112601749B (en) | 2018-06-19 | 2024-03-26 | 艾吉因生物股份有限公司 | Benzodiazepine derivatives, compositions and methods for treating cognitive impairment |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES413944A1 (en) | 1972-04-20 | 1976-06-01 | Merz & Co | Drugs or medicines for influencing the central nervous system |
US4233229A (en) | 1978-01-03 | 1980-11-11 | Gaf Corporation | Preparation of salt-free N-acyl taurines |
FR2457281A1 (en) | 1979-05-23 | 1980-12-19 | Meram Lab | NOVEL 3-AMINOPROPANESULFONIC ACID DERIVATIVES WITH ENHANCED MEMBRANE ACTIVITY |
US4582705A (en) * | 1982-07-12 | 1986-04-15 | Leonard Primes | Composition for detoxification |
EP0392059B1 (en) | 1989-04-14 | 1993-09-15 | Merz & Co. GmbH & Co. | Use of adamantane derivatives in the prevention and treatment of cerebral ischemia |
US5474990A (en) | 1989-10-20 | 1995-12-12 | Olney; John W. | Barbiturates as safening agents in conjunction with NMDA antagonists |
US5081703A (en) * | 1990-06-27 | 1992-01-14 | Pactel Corporation | Satellite mobile communication system for rural service areas |
US5455279A (en) | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
US5614560A (en) | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
US5262162A (en) | 1991-09-06 | 1993-11-16 | Merz & Co. Gmbh & Co. | Cerebral-activating extract |
DE4225730C2 (en) | 1992-08-04 | 2003-04-30 | Merz Pharma Gmbh & Co Kgaa | Process for the preparation of solid dosage forms with protracted 2-stage release |
US5602150A (en) | 1992-10-02 | 1997-02-11 | Research Foundation For Mental Hygiene, Inc. | Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia |
US5952389A (en) * | 1998-01-13 | 1999-09-14 | Synchroneuron | Methods of treating tardive dyskinesia and other movement disorders |
-
1998
- 1998-11-18 US US09/193,892 patent/US6294583B1/en not_active Expired - Lifetime
-
1999
- 1999-11-18 AU AU17347/00A patent/AU1734700A/en not_active Abandoned
- 1999-11-18 WO PCT/US1999/027343 patent/WO2000028999A2/en active Application Filing
-
2001
- 2001-06-27 US US09/893,244 patent/US7498361B2/en not_active Expired - Fee Related
-
2006
- 2006-01-25 US US11/340,802 patent/US7745493B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020013366A1 (en) | 2002-01-31 |
US20060128802A1 (en) | 2006-06-15 |
WO2000028999A3 (en) | 2000-07-20 |
US7745493B2 (en) | 2010-06-29 |
US6294583B1 (en) | 2001-09-25 |
WO2000028999A2 (en) | 2000-05-25 |
US7498361B2 (en) | 2009-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1734700A (en) | Methods of treating tardive dyskinesia and other movement disorders | |
AU5797099A (en) | Concealed colostomy apparatus and method | |
AU5338099A (en) | Method of advertising | |
AU4597297A (en) | Trans-sodium crocetinate, methods of making and methods of use thereof | |
AU1532297A (en) | Starch-emulsifier composition and methods of making | |
AU3091897A (en) | Surf-or-sail-board and method of producing the same | |
AU3068699A (en) | Skin equivalent and methods of forming and using same | |
AU2389600A (en) | Reservoir-and-filter system and method of use | |
AU4890997A (en) | Rayleigh-breakup atomizing devices and methods of making rayleigh-breakup atomizing devices | |
AU4831399A (en) | Leafy cotyledon1 genes and their uses | |
AU4041897A (en) | Golf towel and method | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU4215399A (en) | Dermatological compositions and methods | |
AU5733098A (en) | Inlaid portfolio and method of making | |
AU6260999A (en) | Methods of treating chronic pain | |
AU6270799A (en) | Firestarter and method of making same | |
AU3118297A (en) | Sok-1 and methods of use | |
AU1919699A (en) | Micro-catheters and methods of their manufacture | |
AU3200197A (en) | New composition and methods | |
EP0769667A3 (en) | Refrigerating and/or freezing apparatus | |
AU2388800A (en) | Stable subtilin and methods of manufacture | |
AU2405397A (en) | Thienopyridine derivatives and their use | |
AU1933297A (en) | Manufacture of elongate members | |
AU5878398A (en) | Evaporator making method, such evaporator and use thereof | |
AU4195399A (en) | Lobster ranching methods and structures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |